The Single-Matrix Digit Cancellation Test, a Screener for Selective Attention Deficits : Standardization in an Italian Population Sample and Clinical Usability in Acute Stroke Patients
© 2023 S. Karger AG, Basel..
INTRODUCTION: This study aimed at validating and providing Italian norms for the Single-Matrix Digit Cancellation Test (SMDCT), a cancellation task to screen for selective attention deficits, as well as providing clinical usability evidence for it in acute stroke patients.
METHODS: The SMDCT stimulus is a specular, 4-quadrant, horizontally oriented matrix, across which target distribution is homogeneous. Both accuracy (-A) and time (-T) outcomes were computed. N = 263 healthy participants (HPs) and N = 76 acute stroke patients were recruited. N = 108 HPs also underwent the Mini-Mental State Examination, Frontal Assessment Battery (FAB), and Trail-Making Test (TMT), while patients were further assessed by the Mental Performance in Acute Stroke (MEPS). Regression-based norms were derived (equivalent scores). Construct and factorial validity, as well as case-control discrimination, were tested.
RESULTS: The matrix was underpinned by a two-component structure reflecting left and right hits. The SMDCT-T and -A were associated with TMT and FAB scores, respectively. Education predicted the SMDCT-A/-T, whereas age predicted the SMDCT-T only. In patients, the SMDCT converged with the MEPS, also accurately discriminating them from HPs. An index of right-left difference differentiated right- from left-damaged patients.
CONCLUSIONS: The SMDCT is a valid and normed screener for selective attention deficits, encompassing measures of both accuracy and time, whose adoption is encouraged in acute stroke patients. Relatedly, the horizontal disposition of its matrix does allow for the qualitative report of either leftward of rightward biases due to underlying visual or attentional-representational deficits in this population.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Cerebrovascular diseases (Basel, Switzerland) - 53(2024), 1 vom: 01., Seite 62-68 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pasotti, Fabrizio [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cognitive screening |
---|
Anmerkungen: |
Date Completed 09.02.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1159/000531160 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357653432 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM357653432 | ||
003 | DE-627 | ||
005 | 20240326234822.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000531160 |2 doi | |
028 | 5 | 2 | |a pubmed24n1348.xml |
035 | |a (DE-627)NLM357653432 | ||
035 | |a (NLM)37263262 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pasotti, Fabrizio |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Single-Matrix Digit Cancellation Test, a Screener for Selective Attention Deficits |b Standardization in an Italian Population Sample and Clinical Usability in Acute Stroke Patients |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.02.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 S. Karger AG, Basel. | ||
520 | |a INTRODUCTION: This study aimed at validating and providing Italian norms for the Single-Matrix Digit Cancellation Test (SMDCT), a cancellation task to screen for selective attention deficits, as well as providing clinical usability evidence for it in acute stroke patients | ||
520 | |a METHODS: The SMDCT stimulus is a specular, 4-quadrant, horizontally oriented matrix, across which target distribution is homogeneous. Both accuracy (-A) and time (-T) outcomes were computed. N = 263 healthy participants (HPs) and N = 76 acute stroke patients were recruited. N = 108 HPs also underwent the Mini-Mental State Examination, Frontal Assessment Battery (FAB), and Trail-Making Test (TMT), while patients were further assessed by the Mental Performance in Acute Stroke (MEPS). Regression-based norms were derived (equivalent scores). Construct and factorial validity, as well as case-control discrimination, were tested | ||
520 | |a RESULTS: The matrix was underpinned by a two-component structure reflecting left and right hits. The SMDCT-T and -A were associated with TMT and FAB scores, respectively. Education predicted the SMDCT-A/-T, whereas age predicted the SMDCT-T only. In patients, the SMDCT converged with the MEPS, also accurately discriminating them from HPs. An index of right-left difference differentiated right- from left-damaged patients | ||
520 | |a CONCLUSIONS: The SMDCT is a valid and normed screener for selective attention deficits, encompassing measures of both accuracy and time, whose adoption is encouraged in acute stroke patients. Relatedly, the horizontal disposition of its matrix does allow for the qualitative report of either leftward of rightward biases due to underlying visual or attentional-representational deficits in this population | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Cognitive screening | |
650 | 4 | |a Digit cancellation test | |
650 | 4 | |a Neuropsychology | |
650 | 4 | |a Selective attention | |
650 | 4 | |a Stroke | |
700 | 1 | |a Aiello, Edoardo Nicolò |e verfasserin |4 aut | |
700 | 1 | |a Bollani, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Querzola, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Cozzi, Sara |e verfasserin |4 aut | |
700 | 1 | |a Manfrin, Francesca |e verfasserin |4 aut | |
700 | 1 | |a Bruno, Stefania |e verfasserin |4 aut | |
700 | 1 | |a Poletti, Barbara |e verfasserin |4 aut | |
700 | 1 | |a Ticozzi, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Silani, Vincenzo |e verfasserin |4 aut | |
700 | 1 | |a Bottini, Gabriella |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cerebrovascular diseases (Basel, Switzerland) |d 1997 |g 53(2024), 1 vom: 01., Seite 62-68 |w (DE-627)NLM090577663 |x 1421-9786 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2024 |g number:1 |g day:01 |g pages:62-68 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000531160 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 53 |j 2024 |e 1 |b 01 |h 62-68 |